CN102731585B - 一种活性克林霉素磷酸酯化合物及其药物组合物 - Google Patents
一种活性克林霉素磷酸酯化合物及其药物组合物 Download PDFInfo
- Publication number
- CN102731585B CN102731585B CN 201210254951 CN201210254951A CN102731585B CN 102731585 B CN102731585 B CN 102731585B CN 201210254951 CN201210254951 CN 201210254951 CN 201210254951 A CN201210254951 A CN 201210254951A CN 102731585 B CN102731585 B CN 102731585B
- Authority
- CN
- China
- Prior art keywords
- clindamycin phosphate
- degrees
- solution
- ether
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229960002291 clindamycin phosphate Drugs 0.000 title claims abstract description 106
- -1 clindamycin phosphate compound Chemical class 0.000 title abstract description 11
- 239000000203 mixture Substances 0.000 title abstract 2
- UFUVLHLTWXBHGZ-MGZQPHGTSA-N [(2r,3r,4s,5r,6r)-6-[(1s,2s)-2-chloro-1-[[(2s,4r)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] dihydrogen phosphate Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](OP(O)(O)=O)[C@@H](SC)O1 UFUVLHLTWXBHGZ-MGZQPHGTSA-N 0.000 claims abstract description 120
- 238000002360 preparation method Methods 0.000 claims abstract description 30
- 238000000634 powder X-ray diffraction Methods 0.000 claims abstract description 11
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 48
- 239000000243 solution Substances 0.000 claims description 40
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 28
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 23
- 239000013078 crystal Substances 0.000 claims description 23
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 21
- 239000011259 mixed solution Substances 0.000 claims description 21
- 238000003756 stirring Methods 0.000 claims description 21
- 238000002156 mixing Methods 0.000 claims description 14
- 239000012043 crude product Substances 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 12
- 238000001291 vacuum drying Methods 0.000 claims description 11
- 239000012065 filter cake Substances 0.000 claims description 9
- 239000008194 pharmaceutical composition Substances 0.000 claims description 7
- 229940100613 topical solution Drugs 0.000 claims description 7
- 238000003556 assay Methods 0.000 claims description 5
- 238000005406 washing Methods 0.000 claims description 4
- 238000013019 agitation Methods 0.000 claims description 2
- 239000003814 drug Substances 0.000 abstract description 10
- 229940079593 drug Drugs 0.000 abstract description 4
- 150000001875 compounds Chemical class 0.000 abstract description 2
- 230000007774 longterm Effects 0.000 abstract description 2
- 238000002441 X-ray diffraction Methods 0.000 abstract 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- 238000001914 filtration Methods 0.000 description 14
- 238000002347 injection Methods 0.000 description 13
- 239000007924 injection Substances 0.000 description 13
- 239000000843 powder Substances 0.000 description 13
- 238000012360 testing method Methods 0.000 description 8
- 239000000047 product Substances 0.000 description 7
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical class CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- 239000008215 water for injection Substances 0.000 description 6
- 229960002227 clindamycin Drugs 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 238000002425 crystallisation Methods 0.000 description 5
- 238000004108 freeze drying Methods 0.000 description 5
- 230000008025 crystallization Effects 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- 230000008020 evaporation Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 230000002269 spontaneous effect Effects 0.000 description 4
- 230000000845 anti-microbial effect Effects 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000007710 freezing Methods 0.000 description 3
- 230000008014 freezing Effects 0.000 description 3
- 239000012046 mixed solvent Substances 0.000 description 3
- 239000012047 saturated solution Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000005352 clarification Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000008176 lyophilized powder Substances 0.000 description 2
- 239000006166 lysate Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 238000002390 rotary evaporation Methods 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000012982 microporous membrane Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
Images
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
1个月 | 2个月 | 3个月 | 6个月 | 12个月 | |
1 | 99.90% | 99.70% | 99.38% | 99.03% | 98.12% |
2 | 99.88% | 99.63% | 99.27% | 98.98% | 97.86% |
3 | 99.81% | 99.41% | 98.31% | 95.08% | 89.74% |
4 | 99.82% | 99.29% | 97.76% | 94.89% | 87.67% |
5 | 99.78% | 99.24% | 97.21% | 94.01% | 86.12% |
6 | 99.82% | 98.72% | 96.79% | 93.25% | 84.21% |
7 | 99.81% | 98.43% | 95.74% | 92.13% | 82.59% |
3个月 | 6个月 | 9个月 | 12个月 | 18个月 | |
1 | 99.82% | 99.61% | 99.42% | 98.95% | 97.89% |
2 | 99.78% | 99.56% | 99.38% | 98.79% | 97.68% |
3 | 99.68% | 99.07% | 98.13% | 96.29% | 86.32% |
4 | 99.66% | 99.03% | 97.92% | 95.67% | 86.00% |
5 | 99.71% | 98.78% | 97.30% | 94.52% | 85.93% |
6 | 99.70% | 99.10% | 97.19% | 93.35% | 84.79% |
7 | 99.61% | 97.85% | 95.32% | 91.00% | 82.21% |
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210254951 CN102731585B (zh) | 2012-07-23 | 2012-07-23 | 一种活性克林霉素磷酸酯化合物及其药物组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210254951 CN102731585B (zh) | 2012-07-23 | 2012-07-23 | 一种活性克林霉素磷酸酯化合物及其药物组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102731585A CN102731585A (zh) | 2012-10-17 |
CN102731585B true CN102731585B (zh) | 2013-09-11 |
Family
ID=46987959
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201210254951 Expired - Fee Related CN102731585B (zh) | 2012-07-23 | 2012-07-23 | 一种活性克林霉素磷酸酯化合物及其药物组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102731585B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103288894B (zh) * | 2013-06-05 | 2015-08-19 | 天津大学 | 克林霉素磷酸酯甲醇-水溶剂化合物晶体及制备方法 |
CN103288893B (zh) * | 2013-06-05 | 2015-08-19 | 天津大学 | 克林霉素磷酸酯二甲基亚砜溶剂化合物晶体及制备方法 |
CN103304604B (zh) * | 2013-06-28 | 2014-11-19 | 四川省惠达药业有限公司 | 一种克林霉素磷酸酯化合物,其制备方法及其药物组合物 |
CN105213326A (zh) * | 2014-05-30 | 2016-01-06 | 海南通用康力制药有限公司 | 一种注射用克林霉素磷酸酯冻干粉的制备方法 |
CN107880083A (zh) * | 2017-12-21 | 2018-04-06 | 广州白云山天心制药股份有限公司 | 一种克林霉素磷酸酯的精制方法 |
CN110229199B (zh) * | 2019-05-29 | 2022-10-14 | 瑞普(天津)生物药业有限公司 | 一种克林霉素磷酸酯晶型及其制备方法与应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1602889A (zh) * | 2004-08-27 | 2005-04-06 | 北京国仁堂医药科技发展有限公司 | 一种克林霉素磷酸脂粉针剂的制备方法 |
CN101838297A (zh) * | 2009-03-16 | 2010-09-22 | 珠海亿邦制药有限公司 | 克林霉素磷酸酯的晶型及其制备方法 |
CN101928307A (zh) * | 2010-08-24 | 2010-12-29 | 安徽省皖北药业股份有限公司 | 一种克林霉素磷酸酯的结晶方法 |
-
2012
- 2012-07-23 CN CN 201210254951 patent/CN102731585B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1602889A (zh) * | 2004-08-27 | 2005-04-06 | 北京国仁堂医药科技发展有限公司 | 一种克林霉素磷酸脂粉针剂的制备方法 |
CN101838297A (zh) * | 2009-03-16 | 2010-09-22 | 珠海亿邦制药有限公司 | 克林霉素磷酸酯的晶型及其制备方法 |
CN101928307A (zh) * | 2010-08-24 | 2010-12-29 | 安徽省皖北药业股份有限公司 | 一种克林霉素磷酸酯的结晶方法 |
Non-Patent Citations (2)
Title |
---|
蒋忠良 等."克林霉素磷酸酯的合成研究".《同济大学学报(自然科学版)》.2004,第32卷(第12期),第1693-1695页. |
蒋忠良 等."克林霉素磷酸酯的合成研究".《同济大学学报(自然科学版)》.2004,第32卷(第12期),第1693-1695页. * |
Also Published As
Publication number | Publication date |
---|---|
CN102731585A (zh) | 2012-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102731585B (zh) | 一种活性克林霉素磷酸酯化合物及其药物组合物 | |
CN102670527B (zh) | 左旋奥拉西坦的冻干粉针剂及其制备工艺 | |
CN100560062C (zh) | 一种克林霉素磷酸酯冻干粉针及其制备方法 | |
CN102274195B (zh) | 一种奥拉西坦冻干粉针制剂及其制备方法 | |
CN110734465B (zh) | 一种氨基葡萄糖硫酸钾盐的制备方法 | |
CN101928307B (zh) | 一种克林霉素磷酸酯的结晶方法 | |
CN102924483A (zh) | 一种头孢他啶晶体化合物、其制备方法及其无菌混合粉形式的药物组合物 | |
CN110818751B (zh) | 一种硫酸氨基葡萄糖氯化钠复盐的制备方法 | |
CN104530128A (zh) | 一种磷酸特地唑胺二钠盐及其制备方法 | |
CN102643255B (zh) | 一种炎琥宁化合物 | |
CN103232477B (zh) | 一种盐酸头孢替安化合物、其制备方法及其药物组合物 | |
CN112209988B (zh) | 一种茶皂苷元缩氨基硫脲锌配合物及其制备方法与应用 | |
EP4285918A1 (en) | High-stability daptomycin composition for injection, and preparation method therefor and use thereof | |
CN103040855B (zh) | 一种磷酸氟达拉滨的药物组合物及其制备方法 | |
CN102358721B (zh) | 一种更为稳定的乙酰谷酰胺化合物及其药物组合物 | |
CN111000803A (zh) | 一种注射用克林霉素磷酸酯药物组合物的制备工艺 | |
CN103265561A (zh) | 阿洛西林钠化合物、其制备方法及其药物组合物 | |
EP1982721B1 (en) | Method of stabilizing s-adenosyl-l-methionine and stabilized composition | |
CN102627660A (zh) | 一种头孢美唑钠无菌粉及其制备方法 | |
CN102757471B (zh) | 一种新活性三磷酸胞苷二钠化合物及其药物组合物 | |
CN103980279A (zh) | 一种甲氨蝶呤化合物及注射用甲氨蝶呤 | |
CN103735522B (zh) | 一种炎琥宁冻干粉针及其制备方法 | |
CN102698253A (zh) | 一种三磷酸腺苷辅酶胰岛素组合物 | |
CN101302201A (zh) | 用于治疗的硝基咪唑衍生物 | |
CN110314143A (zh) | 注射用右旋奥拉西坦冻干制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20121017 Assignee: HAINAN GOURD DOLL PHARMACEUTICAL Co.,Ltd. Assignor: JIANGXI KANGHUA MEDICAL TECHNOLOGY Co.,Ltd. Contract record no.: 2014360000043 Denomination of invention: New active clindamycin phosphate compound and medicinal composition thereof Granted publication date: 20130911 License type: Common License Record date: 20140304 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200210 Address after: 344000 middle section of Jianchang Avenue, Nancheng County, Fuzhou City, Jiangxi Province Patentee after: Nancheng Second Hospital Address before: No. 30, Lianhe village, Zibu Town, Wannian County, Shangrao City, Jiangxi Province Patentee before: Wannian Ruijin Information Consulting Co.,Ltd. Effective date of registration: 20200210 Address after: No. 30, Lianhe village, Zibu Town, Wannian County, Shangrao City, Jiangxi Province Patentee after: Wannian Ruijin Information Consulting Co.,Ltd. Address before: 330002 H, Pearl Plaza, Jiefang West Road, Jiangxi, Nanchang 1709, China Patentee before: JIANGXI KANGHUA MEDICAL TECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130911 |